Principal investigators and laboratory managers looking to buy BPC 157 for experimental applications require documented purity, analytical verification, and reliable lot consistency. PX1 Research supplies USA-manufactured, high-purity BPC 157 analytical reagents verified through third-party RP-HPLC and mass spectrometry. All compounds are distributed strictly for in vitro and preclinical research applications.
Principal investigators and laboratory managers looking to buy BPC 157 for experimental applications require documented purity, analytical verification, and reliable lot consistency. PX1 Research supplies USA-manufactured, high-purity BPC 157 analytical reagents verified through third-party RP-HPLC and mass spectrometry. All compounds are distributed strictly for in vitro and preclinical research applications.
To buy BPC 157 for laboratory research, qualified investigators should source from specialized suppliers providing lot-specific third-party certificates of analysis (COA) confirming identity and purity via HPLC and mass spectrometry. PX1 Research manufactures high-purity BPC 157 in domestic ISO 17025 accredited facilities, providing full lot traceability, endotoxin assay data, and rapid domestic dispatch strictly for in vitro and animal models.
When planning laboratory experiments involving tissue regeneration models, obtaining reference-grade reagents is critical for reproducible scientific outcomes. Impurities, peptide fragments, or unreacted reagents from low-grade synthesis can distort assay metrics, alter cell viability, or create erratic binding curves in receptor interaction assays. By sourcing from dedicated suppliers who specialize in high-purity compounds across the broader catalog of research peptides, laboratories safeguard their experimental integrity and maintain strict methodological standards.
PX1 Research provides researchers with direct access to highly purified BPC-157 research peptide formulations designed specifically for benchwork. Each lot undergoes comprehensive analytical characterization before release. This commitment ensures that research teams evaluate the pure peptide sequence without confounding variables introduced by synthesis byproducts or container interaction contaminants.
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a partial sequence of human gastric juice protein BPC. Composed of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), it possesses a molecular weight of approximately 1419.5 Da. Unlike many linear peptides that exhibit rapid enzymatic degradation in solution, the primary structure of BPC-157 provides notable conformational stability in acidic environments and enzymatic assays.
In structural biology and chemical characterization studies, BPC-157 is evaluated as a stable, water-soluble sequence. Its primary sequence allows it to participate in complex signaling cascades without requiring specialized lipid carriers for baseline cell-culture stability. Research laboratories studying peptide stability frequently analyze its sequence to understand how specific proline-rich clusters contribute to structural resistance against proteolytic cleavage.
In vitro data indicate that BPC-157 operates primarily as a tissue repair peptide by modulating pathways responsible for angiogenesis and cell migration. In endothelial cell assays, the peptide has been observed to upregulate vascular endothelial growth factor (VEGF) expression and activate the VEGFR2 signaling pathway. This activation triggers downstream signaling events, including the phosphorylation of FAK (focal adhesion kinase) and Paxillin, which are fundamental to cell adhesion, spreading, and directional migration.
Furthermore, preclinical literature suggests that BPC-157 interacts with the nitric oxide (NO) signaling pathway. Rodent models demonstrate that the compound helps modulate endothelin and nitric oxide synthase (NOS) expression, promoting local microvascular stabilization under ischemic or stress-induced conditions. Detailed theoretical descriptions of these molecular cascades are expanded in our dedicated BPC-157 mechanism review.
By stimulating the migration of fibroblasts, tendon cells, and endothelial cells toward chemical gradients, BPC-157 acts as a powerful probe for studying extracellular matrix (ECM) reorganization. Investigators frequently employ cell scratch assays and transwell migration chambers to quantify how varying concentrations of the peptide alter migration velocity and cellular realignment in real time.
A substantial body of preclinical research evaluates BPC-157 for the accelerated repair of tendon, ligament, and skeletal muscle tissues following acute mechanical trauma. In transected rat Achilles tendon models, administration of the peptide resulted in significantly enhanced structural healing, increased collagen deposition, and superior tensile strength compared to control groups. Histological evaluations revealed organized collagen fiber alignment and reduced inflammatory infiltrate at the lesion site.
Similarly, in animal models of ligament tears and muscle crush injuries, BPC-157 demonstrated an ability to accelerate functional recovery and muscle fiber regeneration. The observed acceleration of connective tissue repair is linked to increased expression of growth factor receptors and enhanced outgrowth of tendon fibroblasts (tenocytes) from explant cultures. Researchers interested in broader connective tissue pathways often review data across our angiogenesis research peptides library to compare distinct molecular targets.
Beyond musculoskeletal models, BPC-157 is widely studied for its protective and restorative effects on the gastrointestinal tract. In rodent models of inflammatory bowel disease (IBD), gastric ulcers, and NSAID-induced enteropathy, BPC-157 administration consistently attenuated mucosal damage and supported structural repair of the gut lining.
Preclinical studies suggest that this mucosal protection is driven by the preservation of tight junction proteins (such as occludin and zonula occludens-1), alongside the downregulation of pro-inflammatory cytokines including TNF-alpha and IL-6. The compound's capacity to preserve gut barrier integrity under chemical insult makes it a reference tool in gastroenterology research focused on epithelial restoration, mucosal healing mechanisms, and intestinal permeability assays.
When constructing experimental frameworks for tissue regeneration, researchers often evaluate BPC-157 alongside alternative signal peptides. While BPC-157 primarily targets localized microvascular formation, focal adhesion kinase signaling, and gastrointestinal mucosal repair, other peptides act via distinct signaling pathways. Understanding these biochemical distinctions allows laboratories to select the precise reagent necessary for specific cell lines or animal assays.
For instance, TB-500 (a fragment of Thymosin Beta-4) operates predominantly through actin sequestration and cell motility pathways, facilitating systemic cell movement and tissue remodeling. Meanwhile, GHK-Cu functions as a copper-binding peptide that modulates gene expression involved in collagen synthesis, matrix metalloproteinase regulation, and antioxidant defense. Researchers exploring combination protocols often investigate TB-500 BPC-157 synergy to examine potential additive effects on cell migration velocity and structural matrix recovery in vitro.
Proper handling and reconstitution protocols are vital to preserve peptide integrity and prevent premature enzymatic or structural degradation. BPC-157 is supplied as a sterile, lyophilized cake or powder. For reconstitution, laboratory personnel should utilize sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4), depending on downstream assay requirements.
Reconstitution should be performed by allowing the diluent to flow slowly down the inner glass wall of the vial, followed by gentle swirling or rotation. Mechanical agitation, such as vigorous shaking or high-speed vortexing, should be strictly avoided as shear forces can cause peptide denaturation or aggregation. Once reconstituted, stock solutions should be aliquoted into single-use polypropylene microtubes to eliminate freeze-thaw cycles. Detailed guidelines for buffer selection and handling are available through the PX1 research library.
Lyophilized BPC-157 maintains chemical stability for extended periods when stored under controlled environmental conditions. Sealed vials should be stored at -20°C for long-term preservation, protected from light and moisture ingress. Storage at 2°C to 8°C is acceptable for short-term holds prior to reconstitution.
Following reconstitution, liquid solutions exhibit limited shelf life and should be stored at 2°C to 8°C for immediate use within 14–28 days (if reconstituted with bacteriostatic water containing 0.9% benzyl alcohol). For prolonged cell culture assays requiring non-preserved diluents (e.g., standard PBS), reconstituted solutions should be used immediately or stored at -80°C. Repeated temperature fluctuations must be minimized to maintain structural integrity and prevent degradation into short fragment sequences.
To ensure high experimental reproducibility, research procurement teams must thoroughly evaluate supplier analytical metrics before placing orders. High-performance liquid chromatography (RP-HPLC) provides quantitative data regarding chemical purity, identifying residual impurities or synthesis byproducts. Mass spectrometry (MS) confirms exact molecular weight, verifying correct sequence synthesis.
In addition to identity and purity testing, verification of low bacterial endotoxin levels is essential for cell culture and animal safety. High endotoxin content can induce non-specific inflammatory responses, invalidating cytokine or immune response assays. Laboratory managers are encouraged to review our published endotoxin testing standards to understand acceptable threshold limits for analytical reagents.
PX1 Research enforces rigorous quality assurance by providing lot-specific, third-party Certificates of Analysis (COAs) generated by accredited ISO 17025 laboratories for every batch released. For high-volume academic and industrial research labs requiring consistent supply chains, custom quotes and volume tiers can be established through our bulk peptide procurement portal.
PX1 Research serves as a trusted partner for university laboratories, biotechnology institutions, and independent research facilities across the United States. All products are manufactured in domestic, GMP-compliant facilities under strict quality management systems. Orders are fulfilled rapidly with same-day dispatch (Monday–Friday) from distribution centers located in California and Arizona.
By prioritizing analytical precision, lot-to-lot consistency, and comprehensive documentation, PX1 Research removes supply chain ambiguity. When purchasing BPC-157 for experimental use, research teams receive reference-grade materials engineered to meet the stringent demands of modern scientific inquiry.
What is the purity level of BPC 157 from PX1 Research?
PX1 Research guarantees a minimum purity of 99% for BPC 157, verified via reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry (MS) for every production lot.
How can I access the Certificate of Analysis (COA) for my BPC 157 lot?
Every product shipment includes access to a lot-specific COA. Researchers can also view or download third-party analytical reports directly from the PX1 Research website by matching their lot number.
What diluents should be used to reconstitute BPC 157 for lab work?
BPC 157 is commonly reconstituted using sterile bacteriostatic water (containing 0.9% benzyl alcohol) for multi-use laboratory storage, or sterile phosphate-buffered saline (PBS, pH 7.4) for sensitive cell culture assays.
What are the recommended storage temperatures for lyophilized BPC 157?
Lyophilized BPC 157 should be stored at -20°C for long-term stability. For short-term storage prior to reconstitution, maintaining temperatures between 2°C and 8°C protected from light is suitable.
Are PX1 Research peptides tested for bacterial endotoxins?
Yes. Every batch of BPC 157 undergoes chromogenic LAL (Limulus Amebocyte Lysate) testing to verify that endotoxin levels remain strictly below established laboratory research thresholds.
How does BPC 157 differ from TB-500 in preclinical research models?
While BPC 157 acts primarily on localized focal adhesion kinase pathways, VEGFR2 expression, and mucosal repair, TB-500 (Thymosin Beta-4 fragment) functions predominantly through actin monomer sequestration and cell migration pathways.
Where is PX1 Research BPC 157 manufactured and shipped from?
PX1 Research peptides are synthesized in GMP-compliant facilities within the USA. Orders ship same-day (Monday through Friday) from fulfillment centers located in California and Arizona.
Can BPC 157 be purchased for human consumption or medical use?
No. All compounds provided by PX1 Research are strictly intended for laboratory research, in vitro assays, and preclinical animal models. They are not for human or veterinary use, therapy, or clinical administration.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.